Compare FDC LTD. with Procter & Gamble Health - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs PROCTER & GAMBLE HEALTH - Comparison Results

PROCTER & GAMBLE HEALTH 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. PROCTER & GAMBLE HEALTH FDC LTD./
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 16.2 52.3 30.9% View Chart
P/BV x 2.2 4.7 46.2% View Chart
Dividend Yield % 0.0 10.0 -  

Financials

 FDC LTD.   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    FDC LTD.
Mar-18
PROCTER & GAMBLE HEALTH
Dec-18
FDC LTD./
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs3193,549 9.0%   
Low Rs1641,301 12.6%   
Sales per share (Unadj.) Rs61.6511.4 12.1%  
Earnings per share (Unadj.) Rs9.961.3 16.2%  
Cash flow per share (Unadj.) Rs12.074.0 16.2%  
Dividends per share (Unadj.) Rs0440.00 0.0%  
Dividend yield (eoy) %018.1 0.0%  
Book value per share (Unadj.) Rs73.2927.8 7.9%  
Shares outstanding (eoy) m174.4016.60 1,050.6%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x3.94.7 82.6%   
Avg P/E ratio x24.339.6 61.3%  
P/CF ratio (eoy) x20.232.8 61.6%  
Price / Book Value ratio x3.32.6 126.3%  
Dividend payout %0717.9 0.0%   
Avg Mkt Cap Rs m42,11840,257 104.6%   
No. of employees `0005.51.1 487.7%   
Total wages/salary Rs m2,1671,313 165.1%   
Avg. sales/employee Rs Th1,943.77,486.7 26.0%   
Avg. wages/employee Rs Th391.71,157.6 33.8%   
Avg. net profit/employee Rs Th313.7897.2 35.0%   
INCOME DATA
Net Sales Rs m10,7518,490 126.6%  
Other income Rs m510244 208.9%   
Total revenues Rs m11,2608,734 128.9%   
Gross profit Rs m2,2671,482 153.0%  
Depreciation Rs m351211 166.4%   
Interest Rs m140-   
Profit before tax Rs m2,4111,514 159.2%   
Minority Interest Rs m-50-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m066 0.0%   
Tax Rs m671563 119.3%   
Profit after tax Rs m1,7351,017 170.5%  
Gross profit margin %21.117.5 120.8%  
Effective tax rate %27.837.1 74.9%   
Net profit margin %16.112.0 134.7%  
BALANCE SHEET DATA
Current assets Rs m7,21315,343 47.0%   
Current liabilities Rs m2,1041,960 107.3%   
Net working cap to sales %47.5157.6 30.1%  
Current ratio x3.47.8 43.8%  
Inventory Days Days5449 111.8%  
Debtors Days Days2828 97.5%  
Net fixed assets Rs m6,8651,209 567.7%   
Share capital Rs m175166 105.5%   
"Free" reserves Rs m12,58615,235 82.6%   
Net worth Rs m12,76115,401 82.9%   
Long term debt Rs m60-   
Total assets Rs m15,04117,595 85.5%  
Interest coverage x173.2NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.70.5 148.1%   
Return on assets %11.65.8 201.1%  
Return on equity %13.66.6 205.8%  
Return on capital %19.010.3 184.8%  
Exports to sales %12.30-   
Imports to sales %00-   
Exports (fob) Rs m1,327NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,8891,636 115.4%   
Fx outflow Rs m04,368 0.0%   
Net fx Rs m1,889-2,732 -69.1%   
CASH FLOW
From Operations Rs m1,498-1,304 -114.9%  
From Investments Rs m20112,697 1.6%  
From Financial Activity Rs m-1,694-301 563.8%  
Net Cashflow Rs m1011,093 0.1%  

Share Holding

Indian Promoters % 68.9 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 4.7 18.2 25.8%  
FIIs % 7.5 1.0 750.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 29.1 65.3%  
Shareholders   23,730 28,591 83.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   DISHMAN PHARMA  ELDER PHARMA  SUVEN LIFESCIENCES  PANACEA BIOTECH  CADILA HEALTHCARE  

Compare FDC LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 292 Points Higher; Automobile and Metal Stocks Witness Buying(Closing)

After opening the day marginally higher, Indian share markets witnessed buying interest throughout the day and ended on a strong note.

Related Views on News

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Oct 15, 2019 03:37 PM

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE FDC LTD. WITH

MARKET STATS